THYROCARE

Thyrocare Technologies Limited

Healthcare Service Provider

Share price

₹530

Market cap

₹8,435 Cr

1Y return

▲ 34%

A healthcare diagnostics provider, Thyrocare Technologies operates a network of diagnostic centers across India delivering laboratory testing and pathology services. The company partners with hospitals, clinics, and independent laboratories to offer affordable diagnostic solutions to patients nationwide. Its distinctive approach combines technology-enabled operations with cost-effective service delivery, making quality diagnostic care accessible across urban and semi-urban markets in India.

Investors holding Thyrocare Technologies Limited

ICICI Prudential Mutual Fund

Mutual Fund

5.57%

HSBC Mutual Fund

Mutual Fund

3.84%

Recent moves 18

Moves18

HSBC Mutual FundIncreased

HSBC Mutual Fund increased its stake in Thyrocare Technologies from 4.75% to 6.63%, buying 29,99,731 shares for ₹187.18 Cr at ₹624.00 apiece, crossing the 5% disclosure threshold.

Docon Technologies Private Limited

13 Aug 2026. Sign in to see this move

ICICI Prudential Mutual FundDecreased

ICICI Prudential Mutual Fund reduced its stake in Thyrocare Technologies from 5.33% to 3.27%, selling 32,62,621 shares in the open market.

Kuwait Investment AuthorityNew position

Kuwait Investment Authority bought 401,000 shares of Thyrocare Technologies for ₹25.02 Cr at ₹624.00 apiece in a block deal on August 13, 2026.

WhiteOak Capital Mutual FundNew position

WhiteOak Capital Mutual Fund bought 641,000 shares of Thyrocare Technologies for ₹40.00 Cr at ₹624.00 apiece in a block deal on August 13, 2026.

Tata AIA Life InsuranceNew position

Tata AIA Life Insurance bought 481,000 shares of Thyrocare Technologies for ₹30.01 Cr at ₹624.00 apiece in a block deal.

Morgan StanleyNew position

Morgan Stanley bought 444,846 shares of Thyrocare Technologies for ₹27.76 Cr at ₹624.00 apiece in a block deal. On the same day, approximately 1.32 crore Thyrocare shares were traded in 15 block deals at ₹624 apiece, totaling ₹821.72 crore.

Morgan StanleyNew position

Morgan Stanley bought 4,56,000 shares of Thyrocare Technologies for ₹28.45 Cr at ₹624.00 apiece in a block deal. On the same day, Thyrocare's promoter, Docon Technologies Private Limited, sold 1,57,69,696 shares, reducing their stake from 60.92% to 51.02% and crossing a disclosure threshold.

Kotak Mahindra Life InsuranceNew position

Kotak Mahindra Life Insurance bought 24 lakh shares of Thyrocare Technologies for ₹149.76 Cr at ₹624.00 apiece in a block deal. This occurred as promoter Docon Technologies sold a 9.90% stake, reducing their holding from 60.92% to 51.02%.

ITI Mutual Fund

13 Aug 2026. Sign in to see this move

Track the whales in Thyrocare Technologies Limited

Get alerted the moment a top investor buys or sells.